Principal Financial Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-14,708
| Closed | -$132K | – | 2459 |
|
2024
Q1 | $132K | Sell |
14,708
-1,682
| -10% | -$15.1K | ﹤0.01% | 2244 |
|
2023
Q4 | $184K | Sell |
16,390
-2,247
| -12% | -$25.3K | ﹤0.01% | 2183 |
|
2023
Q3 | $161K | Buy |
18,637
+1,764
| +10% | +$15.2K | ﹤0.01% | 2200 |
|
2023
Q2 | $175K | Sell |
16,873
-570
| -3% | -$5.9K | ﹤0.01% | 2201 |
|
2023
Q1 | $189K | Sell |
17,443
-1,112
| -6% | -$12.1K | ﹤0.01% | 2193 |
|
2022
Q4 | $208K | Buy |
18,555
+829
| +5% | +$9.3K | ﹤0.01% | 2184 |
|
2022
Q3 | $180K | Buy |
17,726
+52
| +0.3% | +$528 | ﹤0.01% | 2224 |
|
2022
Q2 | $160K | Buy |
17,674
+7,149
| +68% | +$64.7K | ﹤0.01% | 2332 |
|
2022
Q1 | $101K | Buy |
+10,525
| New | +$101K | ﹤0.01% | 2425 |
|
2021
Q4 | – | Sell |
-24,799
| Closed | -$184K | – | 2628 |
|
2021
Q3 | $184K | Buy |
24,799
+9,949
| +67% | +$73.8K | ﹤0.01% | 2445 |
|
2021
Q2 | $216K | Buy |
14,850
+740
| +5% | +$10.8K | ﹤0.01% | 2454 |
|
2021
Q1 | $288K | Sell |
14,110
-9,666
| -41% | -$197K | ﹤0.01% | 2288 |
|
2020
Q4 | $422K | Buy |
23,776
+12,222
| +106% | +$217K | ﹤0.01% | 2153 |
|
2020
Q3 | $171K | Sell |
11,554
-572
| -5% | -$8.47K | ﹤0.01% | 2226 |
|
2020
Q2 | $255K | Buy |
12,126
+3,486
| +40% | +$73.3K | ﹤0.01% | 2126 |
|
2020
Q1 | $200K | Buy |
8,640
+373
| +5% | +$8.63K | ﹤0.01% | 2062 |
|
2019
Q4 | $214K | Buy |
+8,267
| New | +$214K | ﹤0.01% | 2124 |
|
2019
Q1 | – | Sell |
-7,907
| Closed | -$202K | – | 2242 |
|
2018
Q4 | $202K | Sell |
7,907
-6,725
| -46% | -$172K | ﹤0.01% | 2131 |
|
2018
Q3 | $478K | Buy |
+14,632
| New | +$478K | ﹤0.01% | 1968 |
|
2018
Q2 | – | Sell |
-9,674
| Closed | -$235K | – | 2306 |
|
2018
Q1 | $235K | Buy |
9,674
+868
| +10% | +$21.1K | ﹤0.01% | 2070 |
|
2017
Q4 | $246K | Buy |
8,806
+234
| +3% | +$6.54K | ﹤0.01% | 2092 |
|
2017
Q3 | $294K | Sell |
8,572
-5,757
| -40% | -$197K | ﹤0.01% | 2029 |
|
2017
Q2 | $571K | Buy |
14,329
+2,931
| +26% | +$117K | ﹤0.01% | 1928 |
|
2017
Q1 | $420K | Buy |
+11,398
| New | +$420K | ﹤0.01% | 1946 |
|